IMMUVANCE (U.S. Trademark Serial Number 88751602) is a United States trademark of CytoDyn Inc.. The goods and services include: therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 providing a website featuring medical information; providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the forgoing excluding information directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; all of the foregoing excluding medical research and scientific research consulting services directed to adjuvants for vaccines and molecular genetics and genomics testing and reporting. The correspondent is Jared M. Barrett of SEED IP LAW GROUP LLP.
This trademark was filed on January 08, 2020 as United States Trademark Application Serial Number 88751602. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
June 10, 2022 – ABANDONMENT NOTICE E-MAILED – AFTER PUBLICATION
June 10, 2022 – ABANDONMENT – AFTER PUBLICATION
June 09, 2022 – TEAS EXPRESS ABANDONMENT RECEIVED
March 24, 2022 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
March 22, 2022 – SOU EXTENSION 3 GRANTED
March 22, 2022 – SOU EXTENSION 3 FILED
March 22, 2022 – TEAS EXTENSION RECEIVED
August 14, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
View full trademark status information at USPTO
Ownership History
CytoDyn Inc.
CytoDyn Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.